Tafinlar
NDC 0078-0682, dabrafenib, capsule, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0682
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202806
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0682 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DABRAFENIB MESYLATE50 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Kinase Inhibitor [EPC]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0682-66 | 00078068266 | 120 CAPSULE in 1 BOTTLE (0078-0682-66) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea
Use it
Look up 0078-0682 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0682 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0682. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.